Lysis of human pancreatic adenocarcinoma cells by autologous hla‐class I‐restricted cytolytic T‐lymphocyte (CTL) clones
- 19 June 1993
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 54 (4), 636-644
- https://doi.org/10.1002/ijc.2910540419
Abstract
From the primary site of a pancreatic adenocarcinoma (patient BE) a permanent cell line (MZ-PC-2) was established in tissue culture. In the course of mixed lymphocyte-tumor-cell cultures (MLTC) with autologous blood-derived lymphocytes, we isolated CTL clones that lysed autologous tumor cells but not autologous EBV-transformed B cells (EBV-B) and not K562. Pre-treatment of MZ-PC-2 cells with IFN-γ was required to obtain significant lysis in 4-hr cytotoxicity assays. IFN-γ was superior to IFN-α in that respect. Among MLTC responder lymphocytes, tumor-reactive CTL proliferated more strongly in response to MZ-PC-2 cells treated with IFN-γ than to untreated tumor cells. Three CTL clones derived from MLTC were chosen for further analysis. They were CD3+, CD8+, TCR-α/β+ and behaved identically in all functional aspects tested. They all expressed the same TCR-β chain, indicating that they descended from a common precursor lymphocyte and were directed against the same antigen. According to antibody-inhibition experiments, BE-CTL recognized their targets via an HLA-B molecule carrying the Bw6 supertypic determinant. Irrespective of pre-incubation with IFN-γ, low levels of tumor-cell lysis, or none, were seen when MZ-PC-2 cells were kept in medium supplemented with autologous serum or serum pooled from healthy volunteers instead of FCS. Lysability was restored when TNF-α was added to human serum. Serum-free medium was found to enhance the susceptibility of MZ-PC-2 cells to lysis by autologous CTL.Keywords
This publication has 30 references indexed in Scilit:
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.The Journal of Experimental Medicine, 1991
- Conserved nucleotide sequences at the 5' end of T cell receptor variable genes facilitate polymerase chain reaction amplificationEuropean Journal of Immunology, 1991
- Selective expansion of a specific anti‐tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor‐infiltrating lymphocytes from a melanoma patient: Cytotoxic activity and T cell receptor gene rearrangementsEuropean Journal of Immunology, 1990
- Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.The Journal of Experimental Medicine, 1989
- The role of CD2/LFA-3 interaction in antigen- and mitogen-induced activation of human T cellsInternational Immunology, 1989
- Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast beta interferons.The Journal of Experimental Medicine, 1988
- Production of stable cytolytic T‐cell clones directed against autologous human melanomaInternational Journal of Cancer, 1987
- A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17Human Immunology, 1980